Login / Signup
Letter: vedolizumab drug levels in cord and maternal blood in women with inflammatory bowel disease-authors' reply.
Uma Mahadevan
S Vermeire
K Lasch
B Abhyankar
F Bhayat
A Blake
M Dubinsky
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
ulcerative colitis
patients with inflammatory bowel disease
pregnancy outcomes
adverse drug
emergency department
drug induced
pregnant women
physical activity